What is Dynatronics?
Founded in 1979, Dynatronics has established itself as a cornerstone in the medical device manufacturing industry. Headquartered in Salt Lake City, Utah, the company focuses on the development and distribution of restorative products designed to improve patient outcomes. Through decades of innovation, Dynatronics has navigated the complexities of the healthcare market, transitioning from a legacy manufacturer to a modern enterprise-level entity. Their product portfolio is engineered to meet the rigorous demands of clinical environments, ensuring that healthcare providers have access to reliable, high-quality restorative tools. The company's longevity is a testament to its ability to adapt to shifting regulatory landscapes and evolving medical needs, maintaining a steady trajectory of growth within the competitive medical technology sector.
How much funding has Dynatronics raised?
Dynatronics has raised a total of $7M across 3 funding rounds:
Share Placement
$4M
Share Placement
$975K
Debt
$2M
Share Placement (2015): $4M with participation from Prettybrook Partners
Share Placement (2016): $975K led by Prettybrook Partners
Debt (2020): $2M supported by PPP
Key Investors in Dynatronics
Prettybrook Partners
A private equity firm focused on long-term value creation and strategic capital deployment in established industrial and healthcare sectors.
PPP
Public-Private Partnership
What's next for Dynatronics?
With the recent infusion of capital, Dynatronics is positioned to enter a new phase of strategic expansion. The company is expected to prioritize the scaling of its core product lines and the optimization of its supply chain to meet increasing enterprise-level demand. By focusing on operational efficiency and market penetration, Dynatronics aims to leverage its historical expertise to capture additional market share. Future initiatives will likely involve the integration of advanced manufacturing processes and the expansion of its distribution network, ensuring that the firm remains at the forefront of the restorative medical device market. This strategic roadmap is designed to drive long-term value for stakeholders while maintaining the company's reputation for clinical excellence and product reliability.
See full Dynatronics company page
